Cellulitis Completed Phase 2 Trials for AFN-1252 (DB12658)

Also known as: Cellulitis, unspecified

IndicationStatusPhase
DBCOND0014773 (Cellulitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01519492A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to StaphylococciTreatment